Compare Ecopetrol SA (EC) vs Johnson & Johnson (JNJ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ecopetrol SA vs Johnson & Johnson — how do they compare? Ecopetrol SA trades at $17.01 (market cap $33.69B), while Johnson & Johnson trades at $259.64 (market cap $626.09B). The key difference: Johnson & Johnson is far larger — about 18.6× Ecopetrol SA's market cap, and Ecopetrol SA pays the higher dividend (3.82%). Which is the better fit depends on your goals.
| EC | JNJ | |
|---|---|---|
Market Cap | $33.69B | $626.09B |
Sector | Energy | Health |
52-Week High | $17.40 | $267.24 |
52-Week Low | $8.56 | $172.78 |
Enterprise Value | $63.86B | $654.37B |
Dividend Yield | 3.82% | 2.06% |
Volume | — | 6,156,228 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Ecopetrol (EC) trades at $17.05, up 1.61% with a bullish technical signal from moving averages. The company reported mixed Q2 2026 earnings, beating EPS estimates but showing declining revenue trends from $119.69T in 2025 to $116.95T projected for 2026. Recent developments include a cybersecurity incident in July 2026 and ongoing acquisition activities in Brazil's energy sector through Brava Energia.
The stock presents a value opportunity with attractive valuation ratios (P/E 11.11, P/S 0.97) but faces headwinds from declining revenue and profit margins. Analyst consensus is cautious with a $15 price target below current levels, while institutional sentiment shows mixed ratings amid operational challenges and cybersecurity risks.
Johnson & Johnson (JNJ) trades at $261.81, up 0.99% on the day and near its 52-week high. The stock exhibits bullish technical signals with strong moving average support, while fundamentals show robust profitability with a net income margin of 21.48% and consistent dividend growth. Recent earnings have mostly beaten expectations, and the company maintains a solid balance sheet with $24.52 billion in cash.
The outlook for JNJ remains positive, supported by analyst consensus and a price target of $284.50. Key opportunities include its defensive healthcare positioning and pipeline strength, though risks involve patent expirations and legal headwinds. The stock offers a stable investment with growth potential in a volatile market.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ecopetrol SA
Ecopetrol SA is a vertically integrated oil company with operations in Latin America and the United States Gulf Coast. Based out of Colombia, the company explores, develops, and conducts production activities in various countries. Ecopetrol works as the primary operator or partner in a joint venture, in a host of assets held onshore and offshore. Along with production, the company refines and markets crude oils and byproducts produced from its fields. Crude products are moved by Ecopetrol through a series of pipelines throughout Colombia, along with a network of third-party production centers and facilities.
Read more on EC →About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →
